<DOC>
	<DOCNO>NCT02992678</DOCNO>
	<brief_summary>Between December 2016 June 2017 , 110 consecutive patient older 18 year schedule undergo diagnostic therapeutic ERCP Anhui Provincial Hospital recruit study . Patients randomize use opaque , seal envelope contain random number assign treat pentoxifylline ( pentoxifylline group ) Placebo ( placebo group ) prevent ERCP pancreatitis .</brief_summary>
	<brief_title>Pentoxifylline Prevention PEP</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>1 . Males female , age &gt; 18 year . 2 . Normal amylase level undergo ERCP . 3 . Signed inform consent form agree followup time . 1 . Medical psychological condition would permit patient complete study sign inform consent . 2 . Patients involve study within 60 day . 3 . Billroth II RouxenY anatomy 4 . Acute pancreatitis . 5. history previous ERCP 6 . Pregnancy history allergy pentoxifylline 7 . Patient treat arterial hypertension 8 . Patient severe coagulopathy 9 . Patient hyper sensibility pentoxifylline 10 . Nursing mother</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>